These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 8584591)

  • 21. Positron tomography demonstrates frontal lobe hypometabolism in progressive supranuclear palsy.
    Goffinet AM; De Volder AG; Gillain C; Rectem D; Bol A; Michel C; Cogneau M; Labar D; Laterre C
    Ann Neurol; 1989 Feb; 25(2):131-9. PubMed ID: 2784043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cerebral metabolic dysfunction in AIDS: findings in a sample with and without dementia.
    van Gorp WG; Mandelkern MA; Gee M; Hinkin CH; Stern CE; Paz DK; Dixon W; Evans G; Flynn F; Frederick CJ
    J Neuropsychiatry Clin Neurosci; 1992; 4(3):280-7. PubMed ID: 1498579
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kraepelinian and non-Kraepelinian schizophrenia subgroup differences in cerebral metabolic rate.
    Buchsbaum MS; Shihabuddin L; Hazlett EA; Schröder J; Haznedar MM; Powchik P; Spiegel-Cohen J; Wei T; Singer MB; Davis KL
    Schizophr Res; 2002 May; 55(1-2):25-40. PubMed ID: 11955961
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Localized cerebellar reductions in benzodiazepine receptor density in human partial epilepsy.
    Savic I; Thorell JO
    Arch Neurol; 1996 Jul; 53(7):656-62. PubMed ID: 8929173
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Region-specific decline of cerebral glucose metabolism in patients with frontotemporal dementia: a prospective 18F-FDG-PET study.
    Grimmer T; Diehl J; Drzezga A; Förstl H; Kurz A
    Dement Geriatr Cogn Disord; 2004; 18(1):32-6. PubMed ID: 15084791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diffuse occipital hypometabolism on [18 F]-FDG PET scans in patients with idiopathic REM sleep behavior disorder: prodromal dementia with Lewy bodies?
    Fujishiro H; Iseki E; Murayama N; Yamamoto R; Higashi S; Kasanuki K; Suzuki M; Arai H; Sato K
    Psychogeriatrics; 2010 Sep; 10(3):144-52. PubMed ID: 20860570
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cortical glucose metabolism in psychiatric wandering patients with vascular dementia.
    Meguro K; Yamaguchi S; Yamazaki H; Itoh M; Yamaguchi T; Matsui H; Sasaki H
    Psychiatry Res; 1996 May; 67(1):71-80. PubMed ID: 8797244
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is amygdalohippocampectomy really selective in medial temporal lobe epilepsy? A study using positron emission tomography with (18)fluorodeoxyglucose.
    Dupont S; Croizé AC; Semah F; Hasboun D; Samson Y; Clémenceau S; Baulac M
    Epilepsia; 2001 Jun; 42(6):731-40. PubMed ID: 11422327
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional imaging correlates of fronto-temporal dysfunction in Morvan's syndrome.
    Toosy AT; Burbridge SE; Pitkanen M; Loyal AS; Akanuma N; Laing H; Kopelman MD; Andrews TC
    J Neurol Neurosurg Psychiatry; 2008 Jun; 79(6):734-5. PubMed ID: 18187476
    [No Abstract]   [Full Text] [Related]  

  • 30. Sex differences in human brain morphometry and metabolism: an in vivo quantitative magnetic resonance imaging and positron emission tomography study on the effect of aging.
    Murphy DG; DeCarli C; McIntosh AR; Daly E; Mentis MJ; Pietrini P; Szczepanik J; Schapiro MB; Grady CL; Horwitz B; Rapoport SI
    Arch Gen Psychiatry; 1996 Jul; 53(7):585-94. PubMed ID: 8660125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cerebral glucose metabolism in patients with frontotemporal dementia.
    Ishii K; Sakamoto S; Sasaki M; Kitagaki H; Yamaji S; Hashimoto M; Imamura T; Shimomura T; Hirono N; Mori E
    J Nucl Med; 1998 Nov; 39(11):1875-8. PubMed ID: 9829574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lid opening apraxia is associated with medial frontal hypometabolism.
    Smith D; Ishikawa T; Dhawan V; Winterkorn JS; Eidelberg D
    Mov Disord; 1995 May; 10(3):341-4. PubMed ID: 7651454
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The relationship between psychiatric symptoms and regional cortical metabolism in Alzheimer's disease.
    Sultzer DL; Mahler ME; Mandelkern MA; Cummings JL; Van Gorp WG; Hinkin CH; Berisford MA
    J Neuropsychiatry Clin Neurosci; 1995; 7(4):476-84. PubMed ID: 8555751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Age and ApoE genotype interaction in Alzheimer's disease: an FDG-PET study.
    Mosconi L; Sorbi S; Nacmias B; De Cristofaro MT; Fayyaz M; Bracco L; Herholz K; Pupi A
    Psychiatry Res; 2004 Feb; 130(2):141-51. PubMed ID: 15033184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Altered frontostriatal relationship in unmedicated schizophrenic patients.
    Biver F; Goldman S; Luxen A; Delvenne V; De Maertelaer V; De La Fuente J; Mendlewicz J; Lotstra F
    Psychiatry Res; 1995 Sep; 61(3):161-71. PubMed ID: 8545500
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thalamic hypometabolism on 18FDG-positron emission tomography in medial temporal lobe epilepsy.
    Hashiguchi K; Morioka T; Yoshida F; Kawamura T; Miyagi Y; Kuwabara Y; Sasaki M; Koga H; Nagata S; Sasaki T
    Neurol Res; 2007 Mar; 29(2):215-22. PubMed ID: 17439707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Positron emission tomography in Alzheimer's disease.
    Duara R; Grady C; Haxby J; Sundaram M; Cutler NR; Heston L; Moore A; Schlageter N; Larson S; Rapoport SI
    Neurology; 1986 Jul; 36(7):879-87. PubMed ID: 3487046
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patterns of cortical activity in schizophrenia.
    Schroeder J; Buchsbaum MS; Siegel BV; Geider FJ; Haier RJ; Lohr J; Wu J; Potkin SG
    Psychol Med; 1994 Nov; 24(4):947-55. PubMed ID: 7892362
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional basis of memory impairment in multiple sclerosis: a[18F]FDG PET study.
    Paulesu E; Perani D; Fazio F; Comi G; Pozzilli C; Martinelli V; Filippi M; Bettinardi V; Sirabian G; Passafiume D; Anzini A; Lenzi GL; Canal N; Fieschi C
    Neuroimage; 1996 Oct; 4(2):87-96. PubMed ID: 9345500
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased temporal lobe glucose use in chronic schizophrenic patients.
    DeLisi LE; Buchsbaum MS; Holcomb HH; Langston KC; King AC; Kessler R; Pickar D; Carpenter WT; Morihisa JM; Margolin R
    Biol Psychiatry; 1989 Apr; 25(7):835-51. PubMed ID: 2785820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.